Clinical evidence suggests tranexamic acid is well-tolerated in darker skin types when formulated appropriately, though individual patch testing is recommended prior to full-face application given the increased risk of contact dermatitis in melanin-rich skin
ROS are byproducts of oxidative phosphorylation and damaged mitochondria are more prone to generate ROS (Bingol and Sheng, 2016)
The FDA warns that these products may be at different dosage levels, increasing the risk of dosing errors
Rationale for, initiation and titration of the basal insulin/GLP-1RA fixed-ratio combination products, IDegLira and IGlarLixi, for the management of type 2 diabetes
Retatrutide is an investigational once-weekly injectable drug designed to treat type 2 diabetes and obesity, made by the drug company Eli Lilly
It achieves this by downregulating pro-inflammatory cytokines, essentially telling the skin's immune response to take it easy